Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Selected for the Province’s Second Batch of Advanced-Level Smart Factory List for 2025


TIME:2025-10-21

【SUMMARY】 Recently, the Hebei Provincial Department of Industry and Information Technology announced the second batch of advanced-level smart factory designations for 2025, with the “Hebei Guangxiang Pharmaceutical Co., Ltd. Smart Factory” project of Shijiazhuang Sihua Pharmaceutical Group’s Hebei Guangxiang Pharmaceutical Co., Ltd. selected as one of the recipients.

Recently, the Hebei Provincial Department of Industry and Information Technology announced the second batch of advanced-level smart factory designations for 2025, with the “Hebei Guangxiang Pharmaceutical Co., Ltd. Smart Factory” project of Shijiazhuang Sihua Pharmaceutical Group’s Hebei Guangxiang Pharmaceutical Co., Ltd. selected as one of the recipients.

According to reports, a smart factory is centered on digital, networked, and intelligent technologies. By deeply integrating advanced technologies such as the Internet of Things, big data, and artificial intelligence with production and manufacturing, it achieves automated production, intelligent management, and data-driven decision-making. As a benchmark for smart manufacturing, smart factories not only provide technological demonstrations and best practices for upstream and downstream enterprises, thereby driving the intelligent upgrade of the industrial chain, but also accelerate the move of industrial clusters toward higher-end development and enhance the overall competitiveness of regional industries. The designation of advanced-level smart factories is conferred through a multi-stage process that includes enterprise application, review and recommendation by the local municipal bureau of industry and information technology, expert evaluation organized by the provincial bureau of industry and information technology, and public announcement.

In recent years, Guangxiang Pharmaceutical has actively advanced its information and digital transformation by building a fully automated, intelligent, and digitally integrated industrial management platform for active pharmaceutical ingredients. This platform integrates process control, data acquisition, and automated control systems, thereby achieving systematic, integrated, automated, and intelligent manufacturing processes. Grounded in API production, the company has deployed a hyper-converged server cloud platform, a digital safety-production platform, an ERP system, and a collaborative office system, creating a secure and efficient data center. On the manufacturing side, leveraging an intelligent DCS system to analyze data in real time enables “one-click” control across the entire production process for multiple products, including caffeine. At the same time, big-data analytics are used to monitor market dynamics, while IoT technologies are employed to track equipment operation, enabling refined operations and driving cost reduction and efficiency gains. In addition, Guangxiang Pharmaceutical has established an information-based safety-production management platform that incorporates dual-control mechanisms and work permit systems into unified oversight, effectively elevating its overall safety-management capabilities.

Currently, Guangxiang Pharmaceutical has obtained numerous international certifications, including CEP, BRC, FSSC 22000, PMDA, KOSHER, and HALAL. Its advanced smart manufacturing capabilities have significantly strengthened market development, facilitated stable partnerships with major global customers, and driven substantial progress in the company’s growth.

Keywords: